Foreign Product Alerts: LX1

Starting date:
December 30, 2014
Type of communication:
Foreign Product Alert (FPA)
Natural health products
Source of recall:
Health Canada
Source of alert:

United States Food and Drug Administration

Undeclared Substance
General Public
Identification number:

These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.

Affected products

  • LX1


Product description

This product is promoted for weight loss.

Hazard identified

The United States Food and Drug Administration (FDA) warned consumers not to use this product after it was found to contain undeclared 1,3-dimethylamylamine (DMAA).

  • DMAA is a drug that is not approved for sale in Canada.

Place of origin


Side effects

Side effects associated with DMAA include high blood pressure, shortness of breath, chest pain, stroke and psychiatric disorders.

What you should do

Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find the products listed above in the Canadian marketplace.

Canadians who have these products are advised not to use them, and should consult with a healthcare professional if they have concerns about their health related to the use of these products.


Drugs and natural health products that are authorized for sale in Canada will have an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.

As of December 16, 2014, no adverse reactions suspected to be associated with the use of these products have been reported to Health Canada.

Report health or safety concerns

To report a side effect to a health product to Health Canada:

  • Call toll-free at 1-866-234-2345
  • Visit Health Canada's Web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax


Select thumbnail to enlarge - opens in a new window